BioLargo, Inc. · OTC:BLGO
BioLargo — Investor Presentation (November 2023)
22 slides from BioLargo's investor presentation, Nov 21, 2023
Slide 1: BioLargo: Better Solutions for Air, Water, Energy
» Blotargo Better Solutions for: Air - Water — Energy Strategy: Stock Symbol: Invent, Prove, Partner BLGO e
Slide 2: Safe Harbor Statement
Safe Harbor Statement All statements, other than statements of historical fact, included in this presentation and management's explanation and discussion of this presentation, regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans
Slide 3: Who we are
Who we are > Innovators, > Passionate about > Driven by a scientists, sustainability and mission to make engineers, and human health life better entrepreneurs
Slide 4: What we do
What we do > Best-in-class > Engineering- > Focus on solutions for forward problems without cleantech problems technologies solutions
Slide 5: The BioLargo Innovation Engine
The BioLargo Innovation Engine /) BioLargo We Make Life Better {QJ Biok.arg9 — snsincering OBioLargo Water — rap Operating Segments Commercializing our Technologies CLYRA’ Medical Technologies Ine Wound irrigation solution Infection controtplatform FDA S10(8) cleared & commercial ‘Mgjor partnerships
Slide 6: Revenue (5+ years)
$ MILLIONS REVENUE (5 % YEARS) Through Q3: $8.0 + $7.9 million + 134% of lastyear's revenue 2018 2019 2020 2021 2022 Trends are not necessarily indicative of future performance 2023 (FIRST THREE QUARTERS ONLY) Biolargo
Slide 7: Revenue and Net Loss
REVENUE AND NET LOSS me Revenue “Net Loss $5.0 $4.0 So 6 $ MILLIONS. $1.0 -$2.0 -$3.0 Trends are not necessarily indicative of future performance
Slide 8: Revenue and SG&A
$ MILLIONS REVENUE AND SG&A “Revenue 2¢SG&A ai Q2 Q3 a4 a Qa Q3 2021 2022 Trends are not necessarily indicative of future performance a4 SG&A increasedaswork | expands to support commercial p a Q2 Q3
Slide 9: Revenue and Net Cash Used in Operating Activities
$ MILLIONS, REVENUE AND NET CASH USED IN OPERATING ACTIVITIES —+Revenue — -eNet cash used/generated in operating activities -$20 Trends are not necessarily indicative of future performance (Biota
Slide 10: Net Stockholder's Equity (5+ Years)
NET STOCKHOLDER'S EQUITY (5+ YEARS) $50 $40 $30 $20 so 2018 2019 2021 2022 2023 (AS OF Q3) $10 $20 430 re not Trends are not necessarily indicative of future performance Geeuxo
Slide 11: Highlights
Highlights Revenue for Q3 increased 85% quarter-over-quarter and 78% compared to same quarter last year > Pooph sales increasing Net loss of $1.5 million for the quarter, compared to $847,000 in Q3 of last year > Decrease in engineering service revenue > R&D expense increase (to $694,000) > Non-cash
Slide 12: POOPH - Consumer pet odor product
POOPH - Consumer pet odor product Product marketed and sold by our partners, award-winning consumer product experts (Ikigai Marketing Works) ONM receives manufacturer's margin and a royalty on sales Business strategy: ramp up sales and sell to a major consumer products company + ONM would receive 20
Slide 13: Pooph - Looking Forward
Pooph - Looking Forward Current status: * Revenues continuing to grow * More retailers continuing to come onboard + Pooph team predicts 20,000+ stores under contract by end of 2023* (~10x increase from June 2023) * Pooph continues to sell via direct-to-consumer, Walmart, Amazon and others + New prod
Slide 14: Aqueous Electrostatic Concentrator (AEC)
=, CARBON FILTRATION/ MEDIA FILTRATION AQUEOUS ELECTROSTATIC CONCENTRATOR AEC A cana oni ae a san nono ath © MT. r= ( BioLargo (Biotacco
Slide 15: Mobile AEC Units Available for Lease, Sale, or Demonstration Now
Mobile AEC Units Available for Lease, Sale, or Demonstration Now (sBlotargo | a5
Slide 16: AEC awareness and marketing
AEC awareness and marketing
Slide 17: Selected by small New Jersey municipality for PFAS project
Selected by small New Jersey municipality as technology for PFAS project — work has already begun (sBiotargo | a7
Slide 18: BioLargo Energy Technologies
1 | BioLargo EN=RGY TECHNOLOGIES Safer Longer lasting Unlimited charge/discharge cycles 100% domestic supply possible Better option for long duration energy storage (LDES)
Slide 19: BioLargo battery manufacturing facility, Oak Ridge, Tennessee
Slide 20: Reasons to be Confident in BioLargo
Reasons to be Confident in BioLargo Proven business model (hybrid licensing model) Strong historical revenue growth and continuing Good cash position, no debt* SG&A not rising significantly with rising revenues Analyst consensus: undervalued Net operating income for ONM expected to continue increasi
Slide 21: Questions
* Garratt-Callahan? Burning + PFAS first industrial client? + Mineral extraction project timing? + Large waste-to-energy projects? * Why has the company passed on big market opportunities? Questions
Slide 22: The BioLargo Family of Companies
The BioLargo Family of Companies BioLargo, Inc. is a sustainable science, technology & full-service enviromental engineering company that makeslifebetter by delivering world-class products and services across a broad range of industries, with a drive to deliver lean water, clean alt, and advanced an